Chimeric Recombinant Hepatitis E Virus-like Particles as an Oral Vaccine Vehicle Presenting Foreign Epitopes
- 1 February 2002
- Vol. 293 (2) , 273-280
- https://doi.org/10.1006/viro.2001.1240
Abstract
No abstract availableKeywords
Funding Information
- Ono Medical Research Foundation
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 42 references indexed in Scilit:
- Reclassification of the Caliciviridae into distinct genera and exclusion of hepatitis E virus from the family on the basis of comparative phylogenetic analysis.Archiv für die gesamte Virusforschung, 2000
- Norwalk Virus Vaccines: Challenges and ProgressThe Journal of Infectious Diseases, 2000
- Prevalence of Antibody to Hepatitis E Virus among Rodents in the United StatesThe Journal of Infectious Diseases, 2000
- Mucosal immunity and tolerance: relevance to vaccine developmentImmunological Reviews, 1999
- Recombinant Norwalk virus–like particles given orally to volunteers: Phase I studyGastroenterology, 1999
- Strategies for mucosal vaccine development.The American Journal of Tropical Medicine and Hygiene, 1999
- Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents.Journal of General Virology, 1998
- Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunizationEuropean Journal of Immunology, 1996
- Stimulation of Secretory Antibody Following Oral Administration of AntigenClinical Infectious Diseases, 1988
- Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding.The Journal of Experimental Medicine, 1988